slc25a13 anticorps (AA 248-505)
Aperçu rapide pour slc25a13 anticorps (AA 248-505) (ABIN1886262)
Antigène
Voir toutes slc25a13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 248-505
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 248 and 505 of Human SLC25A13
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.50-1.500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- slc25a13 (Solute Carrier Family 25, Member 13 (Citrin) (slc25a13))
-
Autre désignation
- SLC25A13
-
Sujet
-
This gene is a member of the mitochondrial carrier family.The encoded protein contains four EF-hand Ca(2+) binding motifs in the N-terminal domain, and localizes to mitochondria.The protein catalyzes the exchange of aspartate for glutamate and a proton across the inner mitochondrial membrane, and is stimulated by calcium on the external side of the inner mitochondrial membrane.Mutations in this gene result in citrullinemia, type II.Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq]
-
Poids moléculaire
- 74 kDa
-
ID gène
- 10165
-
NCBI Accession
- NM_014251, NP_055066
-
Pathways
- Ribonucleoside Biosynthetic Process, Dicarboxylic Acid Transport
Antigène
-